CM Management Portfolio holdings
Top Buys
| 1 |
Charles River Laboratories
CRL
|
+$3.24M |
| 2 |
Alaska Air
ALK
|
+$2.41M |
| 3 |
Royalty Pharma
RPRX
|
+$2.19M |
| 4 |
Everest Group
EG
|
+$1.97M |
| 5 |
HP
HPQ
|
+$1.75M |
Top Sells
| 1 |
TGB
Trekor Metals
TGB
|
+$9.62M |
| 2 |
FOLD
Amicus Therapeutics
FOLD
|
+$5.27M |
| 3 |
Preformed Line Products
PLPC
|
+$5.17M |
| 4 |
CGAU
Centerra Gold
CGAU
|
+$2.87M |
| 5 |
Keurig Dr Pepper
KDP
|
+$2.24M |
Sector Composition
| 1 | Healthcare | 38.22% |
| 2 | Financials | 12.92% |
| 3 | Technology | 11.1% |
| 4 | Industrials | 10% |
| 5 | Consumer Staples | 9.77% |
No holdings matched the selected filter criteria.
Similar funds
CM Management's Q1 2026 Portfolio in Review
As of Q1 2026, CM Management held 79 positions worth $120M, up 0.84% from $119M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
CM Management deployed $5.81M of net new capital in Q1 2026, opening 17 new positions and adding to 26 existing holdings. Its largest new stake was Charles River Laboratories: 17,500 shares worth $3.02M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 36% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Keurig Dr Pepper, an estimated $2.24M trimmed.
- CM Management's largest Q1 2026 buy was Charles River Laboratories: 17,500 shares worth $3.02M.
- CM Management added most to Royalty Pharma in Q1 2026, an estimated $2.19M increase.
- CM Management's biggest Q1 2026 reduction was Keurig Dr Pepper, cutting an estimated $2.24M.
- CM Management fully exited Trekor Metals in Q1 2026, selling an estimated $9.62M.
- CM Management's ten largest holdings make up 39% of its $120M portfolio in Q1 2026.
- CM Management opened 17 new positions and closed 8 in Q1 2026.
- CM Management's portfolio value rose 0.84% quarter-over-quarter to $120M.
Based on CM Management's 13F filing for Q1 2026, filed 8 May 2026.